In agreement with our cell line findings, GSEA results show a positive enrichment of KRAS-mediated gene sets in the transcriptomes of METΔex14-mutant tumours compared to those with high-grade wildtype MET amplification (Figure 1E). The gene discussed is MET; the disease is neoplasm.